Fountain Healthcare Partners

Ermium Therapeutics is a biotech company developing functionally selective immunomodulators targeting CXCR4 for auto-immune disease indications, particularly interferonopathies, including SLE. Priothera is developing an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in patients. XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. Corteria Pharmaceuticals is a spin off biotech company from Sanofi developing first-in-class drugs for the treatment of distinct heart failure subpopulations. Dualyx is a Belgium-based biotech company dedicated to the development of novel Treg based therapies to address the needs of patients with difficult-to-treat autoimmune diseases. Chrono developed a biologically timed transdermal drug delivery system with a behavioral support delivered via an app to help people manage hard-to-treat conditions. Using a proprietary collagen-based technology, Innocoll is developing a portfolio of products to treat post-operative pain and prevent post-surgical adhesions. The platform allows the surgeon to control two tiny articulated microinstruments that offer motion scaling and tremor elimination, improving surgical success rates and patient outcomes.